Effectiveness and Safety of COVID-19 Vaccine in Patients With IBD Treated With Immunomodulatory or Biological Drugs (ESCAPE-IBD)
Clinical trial NCT04769258 · UNKNOWN
Trial details
- NCT number
- NCT04769258
- Sponsor
- Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-03-01
- Primary completion
- 2022-03-01
- Enrollment
- 1380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.